A 29-year-old woman with known asthma presents with daily symptoms that disturb her sleep 3 to 4 nights per week. She uses her short-acting beta-2 agonist inhaler multiple times a day. According to BTS/SIGN guidelines as reflected in CKS, which step-up therapy should be introduced next?